3/31
08:00 am
lfmd
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/25
04:05 pm
lfmd
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Low
Report
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
3/13
06:27 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Low
Report
LifeMD, Inc. (NASDAQ: LFMD) was upgraded by analysts at B. Riley to a "strong-buy" rating.
3/12
08:05 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) had its price target raised by analysts at HC Wainwright from $12.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
LifeMD, Inc. (NASDAQ: LFMD) had its price target raised by analysts at HC Wainwright from $12.00 to $14.00. They now have a "buy" rating on the stock.
3/11
10:27 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.
Medium
Report
LifeMD, Inc. (NASDAQ: LFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.
3/10
08:23 pm
lfmd
https://seekingalpha.com/article/4766316-lifemd-inc-lfmd-q4-2024-earnings-call-transcript [Seeking Alpha]
Medium
Report
https://seekingalpha.com/article/4766316-lifemd-inc-lfmd-q4-2024-earnings-call-transcript [Seeking Alpha]
3/10
05:30 pm
lfmd
LifeMD Reports Fourth Quarter 2024 Results
High
Report
LifeMD Reports Fourth Quarter 2024 Results
3/7
07:07 pm
lfmd
LifeMD, Inc. (LFMD): A Bull Case Theory [Yahoo! Finance]
Medium
Report
LifeMD, Inc. (LFMD): A Bull Case Theory [Yahoo! Finance]
3/7
07:07 pm
lfmd
LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
Medium
Report
LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
3/6
08:11 am
lfmd
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound [Yahoo! Finance]
Medium
Report
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound [Yahoo! Finance]
3/6
08:00 am
lfmd
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
Medium
Report
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
3/5
09:02 am
lfmd
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum [Yahoo! Finance]
Low
Report
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum [Yahoo! Finance]
3/5
08:00 am
lfmd
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
Low
Report
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
2/25
08:05 am
lfmd
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
Medium
Report
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
2/24
08:05 am
lfmd
LifeMD® Announces Entry Into the Behavioral Health Market
Low
Report
LifeMD® Announces Entry Into the Behavioral Health Market
2/13
10:05 am
lfmd
Health-E Commerce® launches new telehealth collaboration with LifeMD™ to make weight management medications accessible through FSA Store® and HSA Store®
Low
Report
Health-E Commerce® launches new telehealth collaboration with LifeMD™ to make weight management medications accessible through FSA Store® and HSA Store®
1/28
08:00 am
lfmd
LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Medium
Report
LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/8
03:52 pm
lfmd
LifeMD, Inc. (NASDAQ: LFMD) had its price target lowered by analysts at KeyCorp from $10.00 to $7.00. They now have an "overweight" rating on the stock.
Low
Report
LifeMD, Inc. (NASDAQ: LFMD) had its price target lowered by analysts at KeyCorp from $10.00 to $7.00. They now have an "overweight" rating on the stock.